WRAP53 is an independent prognostic factor in rectal cancer- a study of Swedish clinical trial of preoperative radiotherapy in rectal cancer patients
暂无分享,去创建一个
Hong Zhang | Xiao-Feng Sun | Hong Zhang | Xiao-Feng Sun | G. Adell | Da-wei Wang | Gunnar Adell | Da-Wei Wang
[1] Hoguen Kim,et al. Differential Gene Expression Profiles of Metastases in Paired Primary and Metastatic Colorectal Carcinomas , 2008, Oncology.
[2] A. Jemal,et al. Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.
[3] R. Shridhar,et al. Radiation therapy for rectal cancer: current status and future directions. , 2010, Cancer control : journal of the Moffitt Cancer Center.
[4] David N. Rider,et al. Single Nucleotide Polymorphisms in the TP 53 Region and Susceptibility to Invasive Epithelial Ovarian Cancer , 2009 .
[5] Stefano Volinia,et al. MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets , 2009, The Journal of pathology.
[6] O. Stål,et al. Apoptosis in rectal carcinoma , 2001, Cancer.
[7] Xiao-Feng Sun,et al. Survivin expression is an independent prognostic factor in rectal cancer patients with and without preoperative radiotherapy. , 2004, International journal of radiation oncology, biology, physics.
[8] Robert Welch,et al. Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer , 2007, International journal of cancer.
[9] J. Fleshman,et al. Adjuvant radiation therapy for rectal carcinoma: predictors of outcome. , 1995, International journal of radiation oncology, biology, physics.
[10] Rieken,et al. [Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer]. , 2001, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].
[11] D. Cunningham,et al. Cost of treating advanced colorectal cancer: a retrospective comparison of treatment regimens. , 1996, European journal of cancer.
[12] J. Steitz,et al. A conserved WD40 protein binds the Cajal body localization signal of scaRNP particles. , 2009, Molecular cell.
[13] Jiandong Chen,et al. Transcriptional Repression of the Anti-apoptoticsurvivin Gene by Wild Type p53* , 2002, The Journal of Biological Chemistry.
[14] H. Zhang,et al. Knockdown of peroxisome proliferator-activated receptor-β induces less differentiation and enhances cell–fibronectin adhesion of colon cancer cells , 2010, Oncogene.
[15] W. R. Bishop,et al. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway , 2002, Oncogene.
[16] R. Lothe,et al. Molecular Cancer Gene Expression Profiles of Primary Colorectal Carcinomas, Liver Metastases, and Carcinomatoses , 2022 .
[17] Xiao-Feng Sun,et al. Anticancer effect of SN-38 on colon cancer cell lines with different metastatic potential. , 2008, Oncology reports.
[18] H. Putter,et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. , 2001, The New England journal of medicine.
[19] Mark Sherman,et al. Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. , 2009, Cancer research.
[20] Xiao-Feng Sun,et al. Protein expression following γ-irradiation relevant to growth arrest and apoptosis in colon cancer cells , 2009, Journal of Cancer Research and Clinical Oncology.
[21] A. Hartmann,et al. Gene expression profiling of colorectal cancer and metastases divides tumours according to their clinicopathological stage , 2004, The Journal of pathology.
[22] L Påhlman,et al. Improved survival with preoperative radiotherapy in resectable rectal cancer. , 1997, The New England journal of medicine.
[23] S. Mahmoudi,et al. WRAP53 promotes cancer cell survival and is a potential target for cancer therapy , 2011, Cell Death and Disease.
[24] Timothy D. Veenstra,et al. A Human Telomerase Holoenzyme Protein Required for Cajal Body Localization and Telomere Synthesis , 2009, Science.